C1 Bio
PrivateLast Round
Seed
Mar 19, 2025
Total Funding Raised
$21M
Company Overview
C1 Bio is a biotechnology company that develops biomanufacturing platforms to convert industrial waste streams into high-performance chemicals and materials for advanced manufacturing.
Sector
Energy & Sustainability
Verticals
Biotechnology, Advanced Materials, Clean Manufacturing, Circular Economy, Waste Management
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
C1 Bio Comparables
Compare C1 Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capra Biosciences | 71% | |
| Lygos | 70% | |
| ZymoChem | 69% |
C1 Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 19, 2025 | ||||
| Grant | Mar 19, 2025 |
C1 Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Planet A Ventures | Seed |
| denkapparat | Seed |
| Maersk Growth | Seed |
| SquareOne Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$16M round led by denkapparat.
C1 Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about C1 Bio's valuation, stock price, and market status.
Is C1 Bio a public or private company?
C1 Bio is a private company.
What is the current stock price of C1 Bio?
C1 Bio is a private company with no public stock price. No recent secondary market data is available.
How much is C1 Bio worth (valuation)?
Valuation information for C1 Bio is not publicly available.
Can I buy C1 Bio stock?
C1 Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was C1 Bio's last funding round?
C1 Bio's most recent funding round was Seed on March 19, 2025.
Who are the main investors in C1 Bio?
Key investors in C1 Bio include denkapparat.
Will C1 Bio IPO soon?
No public IPO plans have been announced for C1 Bio.
How can I track C1 Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor C1 Bio's secondary market activity and sign up for updates.